PAR 5.77% 24.5¢ paradigm biopharmaceuticals limited..

A little taste before mains?, page-27

  1. 339 Posts.
    lightbulb Created with Sketch. 130
    Quote from the MST report
    " The MST valuation is risk adjusted to reflect the probabilities of approval; 55% for KOA and 40.5% for MPs. Positive news of trial results and approval for the EU and US markets is likely to trigger ~ 2X in valuation for each indication."

    If the probabilities of approval alone for KOA is 55%, surely the value would be worth 10X more than the current estimate of $888m.

    So they are stating that its a bet where you have a 55% chance winning (approval) and having a future 10b+ business and they think its worth only $888m. I'd take those odds any day.
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
24.5¢
Change
-0.015(5.77%)
Mkt cap ! $85.80M
Open High Low Value Volume
28.0¢ 29.0¢ 24.0¢ $969.3K 3.648M

Buyers (Bids)

No. Vol. Price($)
6 34182 24.0¢
 

Sellers (Offers)

Price($) Vol. No.
24.5¢ 24689 1
View Market Depth
Last trade - 16.10pm 18/09/2024 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.